NEUROFIBROMATOSIS 1

Clinical trials for NEUROFIBROMATOSIS 1 explained in plain language.

Never miss a new study

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 8 Completed 5

Two-Drug combo takes on painful NF1 tumors in early trial

Disease control Not yet recruiting

This study tests whether combining two drugs, cabozantinib and selumetinib, can safely shrink plexiform neurofibromas in adults and teens (16+) with neurofibromatosis type 1. About 30 participants will receive the drugs in escalating doses to find the best balance of safety and e…

Matched conditions: NEUROFIBROMATOSIS 1

Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control

Last updated May 12, 2026 13:40 UTC

NEUROFIBROMATOSIS 1

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

Two-Drug combo takes on painful NF1 tumors in early trial